Sale!

Endocrine Cancer Gene Panel Test

7,200 د.إ

-25%

The Endocrine Cancer Gene Panel Test, offered at DNA Labs UAE for a cost of 7200 AED, is a comprehensive diagnostic tool designed to identify genetic mutations associated with various types of endocrine cancers. This cutting-edge test analyzes multiple genes simultaneously, providing a detailed genetic profile that can help in the early detection, diagnosis, and management of endocrine cancers, including thyroid, adrenal, and pituitary tumors.

By focusing on specific gene mutations known to be linked with endocrine cancers, the test enables healthcare providers to tailor treatment strategies to the individual patient, potentially improving outcomes and reducing the risk of unnecessary treatments. The results from this panel can also offer valuable information regarding prognosis and the risk of cancer recurrence, as well as help in identifying at-risk family members who may benefit from genetic counseling and testing.

Conducted at the state-of-the-art facilities of DNA Labs UAE, the test ensures accuracy, confidentiality, and support from a team of genetic experts, making it a crucial resource for patients and doctors in the fight against endocrine cancers.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Endocrine Cancer Gene Panel Test

Test Name: Endocrine Cancer Gene Panel Test

Components: EDTA Vacutainer (3 ml)

Price: 7200.0 AED

Sample Condition: Peripheral blood

Report Delivery: 4-6 weeks

Method: NGS

Test Type: Genetics

Doctor: General Physician

Test Department:

Pre Test Information: Endocrine Cancer Gene Panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

The Endocrine Cancer Gene Panel is a genetic test that analyzes a specific set of genes associated with endocrine cancers. These cancers include thyroid cancer, parathyroid cancer, adrenal gland cancer, pancreatic neuroendocrine tumors, and pituitary tumors. The panel typically includes the analysis of genes such as RET, PTEN, SDHB, SDHD, VHL, MEN1, MAX, and others, depending on the specific laboratory performing the test. These genes are known to be involved in the development and progression of endocrine cancers.

The Endocrine Cancer Gene Panel can help identify genetic mutations or alterations that may increase a person’s risk of developing endocrine cancer. It can also help guide treatment decisions and inform family members of their potential risk for the disease. The test is typically performed on a blood or saliva sample and may be recommended for individuals with a personal or family history of endocrine cancer, as well as those with certain clinical features suggestive of a genetic predisposition to the disease.

Test Name Endocrine Cancer Gene Panel Test
Components EDTA Vacutainer (3 ml)
Price 7200.0 AED
Sample Condition Peripheral blood
Report Delivery 4-6 weeks
Method NGS
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information Endocrine Cancer Gene Panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

The Endocrine Cancer Gene Panel is a genetic test that analyzes a specific set of genes associated with endocrine cancers. These cancers include thyroid cancer, parathyroid cancer, adrenal gland cancer, pancreatic neuroendocrine tumors, and pituitary tumors.

The panel typically includes the analysis of genes such as RET, PTEN, SDHB, SDHD, VHL, MEN1, MAX, and others, depending on the specific laboratory performing the test. These genes are known to be involved in the development and progression of endocrine cancers.

The Endocrine Cancer Gene Panel can help identify genetic mutations or alterations that may increase a person’s risk of developing endocrine cancer. It can also help guide treatment decisions and inform family members of their potential risk for the disease.

The test is typically performed on a blood or saliva sample and may be recommended for individuals with a personal or family history of endocrine cancer, as well as those with certain clinical features suggestive of a genetic predisposition to the disease.